Bottom Line: Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and ...
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial led by the company OneChain ...
(Washington, Nov. 10) – Social determinants of health affect the outcomes of many illnesses, and pediatric cancer is no exception. ...
Bottom Line: Incidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in patients ...
Bottom Line: Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune ...
New Orleans, LA – A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to ...
FRANKFURT. The immune system of vertebrates is a powerful weapon against external pathogens and cancerous cells. T cells play a ...
Nutley, NJ, August 11, 2022 – A new publication in a major journal by scientists from the Hackensack Meridian Center ...
A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view. T-cell immunotherapy is already leading ...
In a first-of-its-kind experiment, researchers have identified links between 127 genes and immune diseases, providing newfound insights into the sequence ...
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against ...
NEW ORLEANS – A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs ...
Philadelphia, March 10, 2022—Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with ...
Bottom Line: T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 ...
T-cell receptors (TCRs), found on the surface of antigen specific T-lymphocytes, are incredibly diverse proteins that are programmed to recognize ...
MUSC Hollings Cancer Center researcher Leonardo Ferreira, Ph.D., well-regarded for his pioneering work with regulatory T-cells, published a paper in Frontiers in Immunology that ...
Oncotarget published "Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia" which reported that mechanistically, 5Z7O-mediated ...
Cold Spring Harbor, NY. -- Cold Spring Harbor Laboratory Press (CSHLP) announced the release of T-Cell Memory, available on its website ...
